title: Is partial-ALPPS safer than ALPPS? A single-center experience.
authors.affiliation: *Department of Surgery, Swiss HPB & Transplantation Center, University Hospital Zurich, Zurich, Switzerland; and †Hospital Paul Brousse, Université Paris Sud, Paris, France.
authors.forename: Henrik
authors.initials: H
authors.lastname: Petrowsky
authors.forename: Georg
authors.initials: G
authors.lastname: Györi
authors.forename: Michelle
authors.initials: M
authors.lastname: de Oliveira
authors.forename: Mickaël
authors.initials: M
authors.lastname: Lesurtel
authors.forename: Pierre-Alain
authors.initials: PA
authors.lastname: Clavien
mesh_terms: D000328:Adult; D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000601:surgery; D002423:Cause of Death; D018281:Cholangiocarcinoma / Q000601:surgery; D005260:Female; D006498:Hepatectomy / Q000009:adverse effects / Q000379:methods* / Q000401:mortality; D017052:Hospital Mortality; D006801:Humans; D006984:Hypertrophy / Q000209:etiology / Q000517:prevention & control; D008026:Ligation / Q000379:methods; D008099:Liver / Q000473:pathology*; D008113:Liver Neoplasms / Q000556:secondary / Q000601:surgery; D008297:Male; D008875:Middle Aged; D011169:Portal Vein / Q000601:surgery; D016896:Treatment Outcome